Understanding hepatitis C intervention success-Qualitative findings from the HepCATT study.


Harris, M; Bonnington, O; Harrison, G; Hickman, M; Irving, W; HepCATT team, ; , COLLABORATORS; Roberts, K; Waldron, CA; Bevan, J; Simpson, C; Homan, C; Reeve, D; Hathaway, C; Purcell, S; Oelbaum, S; Whitfield, J; Jennings, S; Dreha, R; Byrne, T; Thomas, D; Fraser, E; Toyne, K; Newton, P; Hensley, F; Hewish, S; Rutkowski, R; Christian, A; Smith, S; Ward, E; Rhodes, T; Lattimore, S; Mandal, S; Simmons, R; Sreedharan, A; Murray, K; Richardson, P; Caldwell, H; Gore, R; Hughes, A; Walters, C; Orton, A; Lee, P; Ryder, S; Thomson, B; Montgomery, A; Foster, G; (2018) Understanding hepatitis C intervention success-Qualitative findings from the HepCATT study. Journal of viral hepatitis. ISSN 1352-0504 DOI: https://doi.org/10.1111/jvh.12869

[img] Text - Accepted Version
Restricted to Repository staff only until 25 January 2019.
License:

Download (599kB) | Request a copy

Abstract

The United Kingdom has committed to eliminating viral hepatitis as a public health threat. Innovative interventions for marginalized populations are required to realize this goal. In 2016, the HepCATT study team implemented a complex hepatitis C (HCV) intervention in three English drug treatment services, with five controls. We report qualitative study findings from two intervention sites to explore intervention success and transferability potential. The intervention comprised multiple components, including a nurse facilitator, peer support and education initiatives. Qualitative data were generated at baseline (2014) and post-intervention (2016) at two sites through in-depth interviews, focus groups and observations. The 96 participants comprised drug service and intervention providers and clients with an injecting history. Data were triangulated and thematically analysed. Client engagement with a HCV treatment service rose from 16 at baseline to 147 in 2016. There was no comparable increase at the five control sites. Baseline testing and treatment barriers included the following: limited HCV knowledge; fear of diagnosis and treatment; precarious living circumstances and service-specific obstacles. Treatment engagement was aided by intervention timeliness; improved communication structures; personalized care; streamlined testing and treatment pathways; peer support. Multiple interrelated components influenced the increased levels of treatment engagement documented in HepCATT. The nurse facilitator, involved in implementation and innovation, was key to intervention success. Baseline barriers correspond with international literature-indicating transferability potential. Control data indicate that biomedical innovation alone is not sufficient to increase engagement among the most marginalized. Sustainable resourcing of community services is crucial to effect change.

Item Type: Article
Faculty and Department: Faculty of Public Health and Policy > Dept of Social and Environmental Health Research
PubMed ID: 29369467
URI: http://researchonline.lshtm.ac.uk/id/eprint/4646789

Statistics


Download activity - last 12 months
Downloads since deposit
1Download
54Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item